Investors

Egetis is an innovative, unique, and integrated pharmaceutical drug development company, focusing on projects in late-stage development for treatment of serious rare/niche diseases with significant unmet medical needs in the orphan drug segment

IR-contact

 

 

 

Karl Hård, Head of Investor Relations & Communications
karl.hard@egetis.com Phone: +46 733 011 944

Nicklas Westerholm, CEO
nicklas.westerholm@egetis.com

Yilmaz Mahshid, CFO
yilmaz.mahshid@egetis.com

Calendar and upcoming reports

October 13, 2022
Capital Markets Day

November 8, 2022
Interim report January - September

Show more events

Share

Twitter
LinkedIn

Contact us

Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden

Phone: +46 8 679 72 10

E-mail: info@egetis.com